Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 8,948 shares, an increase of 54.0% from the July 30th total of 5,810 shares. Based on an average trading volume of 55,645 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.0% of the shares of the company are short sold.
Merck KGaA Price Performance
OTCMKTS MKKGY traded up $0.24 during trading hours on Tuesday, reaching $32.69. The company’s stock had a trading volume of 1,888 shares, compared to its average volume of 93,992. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.51 and a quick ratio of 1.00. Merck KGaA has a 1-year low of $23.73 and a 1-year high of $34.19. The company’s 50-day moving average is $32.44 and its two-hundred day moving average is $29.49. The firm has a market capitalization of $21.13 billion, a price-to-earnings ratio of 16.85, a P/E/G ratio of 2.66 and a beta of 0.98.
Analyst Ratings Changes
Several analysts have commented on MKKGY shares. UBS Group cut shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Jefferies Financial Group assumed coverage on Merck KGaA in a research report on Tuesday, May 26th. They set a “hold” rating on the stock. HSBC upgraded Merck KGaA to a “hold” rating in a research note on Monday, July 6th. Finally, Zacks Research downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Six analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.
About Merck KGaA
Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.
Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Salesforce Looks Overbought, But the Rally May Be Far From Over
- Radar Anomaly: Draganfly’s Options Surge Signals Strategy Shift
- Boarding Call: EHang Secures First-Mover Altitude
- 3 Space Stocks: Ready for Liftoff or Burning Up on Reentry?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
